L. Zoute et al. / Tetrahedron Letters 52 (2011) 2473–2475
2475
Chemistry; Wiley-VCH: Weinheim, 2004; Biomedical Frontiers of Fluorine
Chemistry; Ojima, I., McCarthy, J. R., Welch, J. T., Eds.; American Chemical
Society: Washington, D. C., 1996; (e) Mikami, K.; Itoh, Y.; Yamanaka, M. Chem.
Rev. 2004, 104, 1–16.
we observed the formation of the corresponding a-fluoro-b-hydro-
xy esters 6 (dr: 60:40) as a result of the reduction of the second car-
bon–bromine bond by another equivalent of Et2Zn (Scheme 2). This
was confirmed by the quantitative preparation of 6 (dr: 60:40) by
reacting isolated bromohydrine 5c with Et2Zn in THF at rt. Interest-
ingly, with lactones, the reaction occurs with good to excellent dia-
stereoselectivity. This last phenomenon is still unclear and is
actually under study within our laboratory. Moreover, it is gener-
ally assumed that this type of reaction goes through the formation
of zinc enolate. This zinc enolate has never been observed in our
case especially by NMR spectroscopy.
3. (a) Zoute, L.; Dutheuil, G.; Quirion, J. C.; Jubault, P.; Pannecoueke, X. Synthesis
2006, 3409–3418; (b) Zoute, L.; Lacombe, C.; Quirion, J. C.; Charette, A. B.;
Jubault, P. Tetrahedron Lett. 2006, 47, 7931–7933; (c) Lemonnier, G.; Zoute,
L.; Dupas, G.; Quirion, J. C.; Jubault, P. J. Org. Chem. 2009, 74, 4124–4131; (d)
Lemonnier, G.; Zoute, L.; Quirion, J. C.; Jubault, P. Org. Lett. 2010, 12, 844–
846.
4. Tarui, A.; Kawashima, N.; Sato, K.; Omote, M.; Miwa, Y.; Minami, H.; Ando, A.
Tetrahedron Lett. 2010, 51, 2000–2003.
5. Tarui, A.; Kawashima, N.; Sato, K.; Omote, M.; Ando, A. Tetrahedron Lett. 2010,
51, 4246–4249.
6. Ishihara, T.; Matsuda, T.; Imura, K.; Matsui, H.; Yamanaka, H. Chem. Lett. 1994,
23, 2167–2170.
7. (a) Iseki, K.; Kuroki, Y.; Kobayashi, Y. Synlett 1998, 437–439; (b) Iseki, K.;
Kuroki, Y.; Kobayashi, Y. Tetrahedron 1999, 55, 2225–2236.
8. Mima, K.; Ishihara, T.; Kuwahata, S.; Konno, T.; Yamanaka, H. Chem. Lett. 2002,
31, 192–193.
9. Ishihara, T.; Mima, K.; Konno, T.; Yamanaka, H. Tetrahedron Lett. 2002, 43,
3493–3497.
To conclude, we have developed a one-step and versatile meth-
od to prepare
a-bromo-a-fluoro-b-hydroxy esters starting from
commercially available reagents. These highly functionalized fluo-
rinated building blocks can be prepared from aldehydes and for the
first time from ketones and lactones. Except in the case of lactones,
no diastereoselectivity was observed.
10. Typical procedure: To a dry THF solution (10 ml) of the carbonyl compound
(1 mmol, 1 equiv) and ethyl dibromofluoroacetate 1 (2 mmol., 2 equiv) was
added diethylzinc (1 M in hexane, 2 mmol, 2 equiv) under argon. The reaction
mixture was stirred for 3 hours at room temperature. The resulting solution
was then quenched with ethanol (15 ml), stirred for 15 min, and concentrated
under reduced pressure. The residue was taken up in Et2O (5 ml), filtered over
celite and purified by chromatography on silica gel (eluent/cyclohexane–
EtOAc), affording the expected product.
11. Spectroscopic data for anti- and syn- isomers of ethyl 2-bromo-2-fluoro-3-
hydroxy-3-(4-(trifluoromethyl)phenyl)propanoate (4c). anti-4c: colorless oil.
Rf = 0.25 (15% EtOAc/cyclohexane). 1H NMR (300 MHz, CDCl3) d: ppm 7.6 (m,
4H), 5.4 (dd, 1H, J = 20.7, 6.4 Hz, 1H), 4.3 (q, J = 7.2 Hz, 2H), 3.5 (d, J = 6.5 Hz,
OH), 1.4 (t, J = 7.2 Hz, 3H); 13C NMR (300 MHz, CDCl3) d: ppm 166.1 (d,
J = 27 Hz, CO), 139.5 (Cq), 131.7 (q, J = 32 Hz, Cq), 129.6 (d, J = 2 Hz, CH), 129.1
(d, J = 2 Hz, CH), 125.5 (dd, J = 8, 4 Hz, CF3), 97.8 (d, J = 276 Hz, CF), 77.8 (d,
J = 20 Hz, CH), 64.2 (CH2), 14.2 (CH3); 19F NMR (282.5 MHz, CDCl3) d: ppm
ꢀ63.2 (s, 3F), ꢀ138.1 (d, J = 20.4 Hz). syn-4c: colorless oil. Rf = 0.17 (15% EtOAc/
cyclohexane). 1H NMR (300 MHz, CDCl3) d: ppm 7.5–7.4 (m, 4H), 5.2 (dd,
J = 15.6, 3.6 Hz, 1H), 4.2 (q, J = 7.2 Hz, 2H), 3.5 (d, J = 3.7 Hz, OH), 1.2 (t,
J = 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3) d: ppm 166.2 (d, J = 26 Hz, CF), 139.5
(Cq), 131.7 (q, J = 32 Hz, Cq), 129.6 (CH),125.5 (m, CF3), 97.8 (d, J = 275 Hz, Cq),
77.7 (d, J = 20 Hz, CH), 64.2 (CH2), 14.2 (CH3); 19F NMR (282.5 MHz, CDCl3) d:
ppm ꢀ63.2 (s, 3F), ꢀ130 .8 (d, J = 16.2 Hz). MS (EI): m/z = u359; IR (neat) 3535,
1737 cmꢀ1. Anal. calcd for C12H11BrF4O3: C, 40.14; H, 3.09. Found: C, 40.22; H,
3.24.
Acknowledgments
This work was supported by MESR (Ministère de l0Enseigne-
ment Supérieur et de la Recherche), the Région Haute-Normandie
(CRUNCH program), and INSA of Rouen. G.L. thanks MESR for a
Ph.D fellowship.
Supplementary data
Supplementary data (experimental procedures; complete spec-
troscopic data for all new compounds) associated with this article
References and notes
1. (a) Purser, S.; Moore, P. R.; Swallow, S.; Gouverneur, V. Chem. Soc. Rev. 2008, 37,
320–330; Begué, J.-P.; Bonnet-Delpon, D. Chimie bioorganique et médicinale du
fluor; CNRS Editions: Paris, 2005; (c) Thomas, C. J. Curr. Top. Med. Chem. 2006, 6,
1529–1543; (d) Kirk, K. L. J. Fluorine Chem. 2006, 127, 1013–1029.
2. For reviews on fluorine-containing organic compounds, see: (a) Hiyama, T.
Organofluorine Compounds: Chemistry Applications; Springer: Berlin, 2000; (b)
Iseki, K. Tetrahedron 1998, 54, 13887–13914; Kirsch, P. Modern Fluoorganic
12. The relative configuration of the syn- and anti-diastereoisomers have been
determined using previously reported methods.7a
a-Bromo-a-fluoro-b-
hydroxy esters could be easily reduced to diols and then converted to
acetonide derivatives.